US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

94.91

-0.7598-0.79%

Post-market: 94.910.00000.00%19:30 EDT

Volume:19.86K

Turnover:1.88M

Market Cap:411.91M

PE:52.93

High:95.59

Open:95.59

Low:94.69

Close:95.67

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:1.80

T/O Rate:0.46%

Dividend:1.55

Dividend Rate:1.63%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.67

PE(LYR):5.09

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026

Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS

Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Political and General News Events from August 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PBE/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":94.91,"timestamp":1789761600000,"preClose":95.6698,"halted":0,"volume":19855,"hourTrading":{"tag":"盘后","latestPrice":94.91,"preClose":94.91,"latestTime":"19:30 EDT","volume":11,"amount":1042.81,"timestamp":1789774205884,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007941900160761269,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Market Closed","change":-0.7598,"latestTime":"09-18 16:00:00 EDT","open":95.59,"high":95.59,"low":94.69,"amount":1884465.847,"amplitude":0.009407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":95.6698,"sharesOutstanding":3180000,"nav":95.66478,"aum":414120917.85,"dividendRate":0.01633,"bidAskSpread":0.002296,"preHourTrading":{"tag":"盘前","latestPrice":93.38,"preClose":95.6698,"latestTime":"07:13 EDT","volume":5,"amount":466.9,"timestamp":1789730023426,"change":-2.2898,"changeRate":-0.023934,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":94.91,"preClose":94.91,"latestTime":"19:30 EDT","volume":11,"amount":1042.81,"timestamp":1789774205884,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8031312986512782,"impliedVol":0.1158,"impliedVolPercentile":0.0398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.8031312986512782,"shares":4340000,"dividePrice":1.5499,"high":95.59,"amplitude":0.009407,"preClose":95.6698,"low":94.69,"week52Low":67.69,"pbRate":"1.67","psRate":"239.95","week52High":98.82,"institutionHeld":0.2552,"latestPrice":94.91,"eps":1.793292,"divideRate":0.01633,"volume":19855,"delay":0,"ttmEps":1.793292,"open":95.59,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":92.91,"twentyDayClose":96.56,"sixtyDayClose":87.3983},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PBE","amount":0.01867,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4534","XBI","LU0128526141.USD","IE0009355771.USD","PBE","TBXU","LU2112291526.USD","BIB","LU2089984988.USD","VRCA","LU1057294990.SGD","BK4139","LU2242646821.SGD","LU0320765992.SGD","AMGN","BK4566","BK4588","LU0889565916.HKD","LU2468319806.SGD","XLV","LU0868494617.USD","HCSG","LU2242652126.USD","BK4585","IE0002141913.USD","LU0058720904.USD","BK4581","IE00B2B36J28.USD","BK4533","LU1023059063.AUD","SG9999001440.SGD","LU0289739699.SGD","BBH","BK4599","IE00BJT1NW94.SGD","BK4137","BK4007","LU0109394709.USD","PJP","LU1061106388.HKD","LABU","LU0029874061.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084083","title":"HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084083","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:01","pubTimestamp":1787839287,"startTime":"0","endTime":"0","summary":"HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 millionHBM Holdings posted revenue of US$122.49 million for the six months ended June 30, 2026, up 20.9","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL77D5HK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PBE","LU2242646821.SGD","BBH","AMGN","BK4533","LU2089984988.USD","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0009355771.USD","LU1057294990.SGD","BK4566","LU1983299246.USD","IE00B4R5TH58.HKD","LU0058720904.USD","BK4599","BK1574","IBB","BK4581","LU1061106388.HKD","PJP","BIB","LU1571399168.USD","02142","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU0868494617.USD","LU0889565916.HKD","IBBQ","BK4585","LU2112291526.USD","TBXU","SG9999001440.SGD","BK1583","LU2242652126.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013447","title":"Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013447?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:15","pubTimestamp":1787829352,"startTime":"0","endTime":"0","summary":"Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","BK4581","LU2242646821.SGD","LU0432979614.USD","IE00BFTCPJ56.SGD","BK4585","BK4139","BBH","LU2237443382.USD","LU2237443465.HKD","LU0868494617.USD","TBXU","LU0708994859.HKD","LU2236285917.USD","LU0122379950.USD","BK4534","PJP","LU2462157665.USD","LU1829250122.USD","LU2237443622.USD","BK4588","BIB","AZNH","AMGN","LU1267930573.SGD","IE0009355771.USD","LU0029864427.USD","LU2237443978.SGD","AZN","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00B3T34201.USD","BK4007","LU0128525929.USD","LU2468319806.SGD","IE0002141913.USD","PBE","LU2456880835.USD","BK4568","BK4566","BK4533","LU2089984988.USD","LU2417539215.USD","IBB","IBBQ","LU1057294990.SGD","LU1023059063.AUD","LU0289739699.SGD","LU2242652126.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","LU2236285917.USD","BK4568","BIB","LU0889565916.HKD","BK4007","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","LU0128525929.USD","LU1267930573.SGD","BK4566","LU0029864427.USD","IE00B3T34201.USD","LU0122379950.USD","LU2237443978.SGD","AZNH","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","BK4581","AZN","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4599","LU0868494617.USD","PBE","AMGN","LU0432979614.USD","LU2456880835.USD","LU2112291526.USD","LU2417539215.USD","LU1829250122.USD","IE00BJT1NW94.SGD","LU2237443895.HKD","BBH","BK4585","LU2242646821.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1267930573.SGD","LU2112291526.USD","LU1057294990.SGD","BK4533","IE00BFTCPJ56.SGD","LU1829250122.USD","LU2237443465.HKD","PBE","LU0889565916.HKD","LU1061106388.HKD","BK4534","LU0868494617.USD","LU0109394709.USD","BK4599","AZNH","LU2242652126.USD","BBH","LU0128525929.USD","LU1983299246.USD","IE00B4R5TH58.HKD","AMGN","BK4581","BIB","IBBQ","LU2462157665.USD","AZN","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2237443622.USD","LU2089984988.USD","LU0708994859.HKD","BK4566","LU1571399168.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0310800379.SGD","PJP","IE00BJT1NW94.SGD","IBB","LU0432979614.USD","LU2456880835.USD","LU2237443382.USD","LU2237443895.HKD","TBXU","LU2237443549.SGD","LU0029864427.USD","BK4585","BK4007","LU2237443978.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775710","title":"Vertex Corp. Added to JPX-Nikkei Mid and Small Cap Index for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775710?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813720,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has been selected as a constituent of the JPX-Nikkei Mid and Small Ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-added-to-jpx-nikkei-mid-and-small-cap-index-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","LU2456880835.USD","VRTX","IE00BJT1NW94.SGD","LU0079474960.USD","JPX","LU2417539215.USD","IBBQ","BK4023","LU0823416689.USD","LU1815336091.USD","BK4567","SG9999013999.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","BK4532","LU0058720904.USD","LU2089984988.USD","PBE","LU0566484027.USD","LU1069344957.HKD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","BK4585","IBB","LU1430594728.SGD","IDNA","GNMX","IE00BJJMRZ35.SGD","LU0432979614.USD","LU1585245621.USD","LU1093756168.USD","LU1778281490.HKD","LU2468319806.SGD","BIB","SG9999001176.USD","VERX","SGXZ57979304.SGD","IE0002141913.USD","BBH","LU0234570918.USD","TBXU","IE0002270589.USD","LU1559883803.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","BK4533","IE00B19Z9Z06.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477574","title":"Vertex Corp. Refines Leadership Structure at Key Subsidiary Vertex Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477574","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477574?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:55","pubTimestamp":1787813711,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Corp. ( ($JP:5290) ). Vertex Corporation has updated its earlier disclosures on changes to directors and offic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-corp-refines-leadership-structure-at-key-subsidiary-vertex-co?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU2456880835.USD","LU1559883803.SGD","LU0320765992.SGD","LU1815336091.USD","IBB","LU2362541273.HKD","LU2362541513.USD","SG9999001176.USD","TBXU","BBH","LU0757428866.USD","BK4139","IE00B19Z3581.USD","LU0079474960.USD","LU0061475181.USD","IE00B19Z9Z06.USD","PBE","VRTX","IE00B19Z9P08.USD","LU1430594728.SGD","LU0234570918.USD","LU0889565916.HKD","IDNA","BK4585","LU0058720904.USD","LU1093756325.SGD","LU2417539215.USD","GNMX","IBBQ","IE00B2B36J28.USD","LU0417517546.SGD","BIB","BK4567","IE0002270589.USD","IE00BJT1NW94.SGD","LU2236285917.USD","LU1035775433.USD","SGXZ57979304.SGD","LU0256863811.USD","LU0109394709.USD","LU0823416689.USD","IE00BZ9MQY76.HKD","VERX","LU1674673428.USD","BK4023","LU0566484027.USD","LU0289739699.SGD","LU2462157665.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662514775","title":"AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662514775","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662514775?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:40","pubTimestamp":1787812818,"startTime":"0","endTime":"0","summary":"UPDATE 3-AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trialAug 27 (Reuters)-AstraZenecaAZN.Lsaid on Thursday its asthma drug Tezspire met the main goals of a late-stage tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN.UK","LU0661504455.SGD","LU1170363599.USD","LU0575583348.USD","LU1057294990.SGD","03165","PBE","TBXU","LU0310799852.SGD","LU1003077747.HKD","LU0266013472.USD","LU0887340254.USD","LU1153584641.USD","IBBQ","IBB","LU0997586432.USD","AMGN","LU0047473722.EUR","LU1481600234.SGD","LU3187612489.SGD","LU2242652126.USD","BK4599","LU1829250122.USD","LU1974910355.USD","LU0640478417.SGD","LU0972486137.USD","REGN","LU0432979614.USD","LU1119994496.HKD","PJP","LU2237443622.USD","LU0345777659.USD","LU0792757196.USD","LU0077335932.USD","LU0823434583.USD","SGXZ57979304.SGD","LU0738911758.USD","IE00BFTCPJ56.SGD","LU1880407132.USD","LU0052756011.USD","BIB","LU0997586515.USD","LU2237443382.USD","LU1571399168.USD","LU0122379950.USD","LU1267930490.SGD","LU2293690082.USD","BK4588","BBH","LU1051770623.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778025","title":"Amgen - Tezspire Safety Profile Consistent with Approved Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778025?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBE","LU0122379950.USD","LU2112291526.USD","BK4599","BK4585","LU2468319806.SGD","TBXU","LU2242652126.USD","BK4581","PJP","LU2242646821.SGD","IE00B2B36J28.USD","BK4534","IE00BFTCPJ56.SGD","AMGN","BK4139","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","LU0868494617.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","LU1057294990.SGD","LU0289739699.SGD","LU1983299246.USD","IE0009355771.USD","SG9999001440.SGD","BK4588","LU0058720904.USD","IE0002141913.USD","IBBQ","BIB","LU1023059063.AUD","LU1571399168.USD","BBH","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728778","title":"Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662728778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA3XV48Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IBB","IE0002141913.USD","IBBQ","AMGN","BK4139","BK4599","BK4533","BK4534","BBH","LU0122379950.USD","LU2089984988.USD","LU0058720904.USD","LU1061106388.HKD","BK4585","LU2468319806.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","PBE","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0889565916.HKD","LU2242652126.USD","BK4581","LU0289739699.SGD","LU2112291526.USD","LU1983299246.USD","BIB","BK4588","LU1571399168.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU0868494617.USD","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662741464","title":"Vertex to Present at Wells Fargo Healthcare Investor Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662741464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662741464?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774425,"startTime":"0","endTime":"0","summary":"Vertex to present at Wells Fargo healthcare investor conference fireside chatVertex will join four investor conference fireside chats in September 2026, led by senior management.Wells Fargo 21st Annua","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7VGD1d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","LU0234570918.USD","LU0320765992.SGD","LU2362540622.SGD","IE00B19Z9Z06.USD","LU0417517546.SGD","BK4139","IE00B2B36J28.USD","IE00B19Z9P08.USD","LU0058720904.USD","LU2468319806.SGD","LU0079474960.USD","TBXU","BBH","BK4533","IE00B4R5TH58.HKD","LU0256863811.USD","BK4567","LU2417539215.USD","LU2362541513.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2362541273.HKD","IE00B19Z3B42.SGD","IBBQ","LU1035775433.USD","IE00B894F039.SGD","LU0432979614.USD","IE0009355771.USD","SGXZ57979304.SGD","LU2089984988.USD","LU0109394709.USD","GNMX","PBE","LU1093756168.USD","LU0889565916.HKD","SG9999001176.USD","LU2462157665.USD","LU1674673691.USD","LU1430594728.SGD","BIB","IE0002141913.USD","LU1674673428.USD","IBB","LU1778281490.HKD","IE00B19Z3581.USD","SG9999013999.USD","LU1069344957.HKD","VRTX","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184267","title":"Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184267","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184267?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:59","pubTimestamp":1787741942,"startTime":"0","endTime":"0","summary":"Biogen CFO Robin Kramer to join Wells Fargo Healthcare Conference fireside chatBiogen will join a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026 at 9:30 a.m. ET.Pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL9qnkfK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","LU0889565916.HKD","PBE","BMED","IE00B19Z9P08.USD","BK4588","LU0109394709.USD","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4585","BK4532","BK4533","LU0234570918.USD","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796495","title":"Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796495?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:32","pubTimestamp":1787733120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 2.1% to 5.74 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 37% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.2% and Amgen Inc. remained unchanged.Trading volume totaled 180.5 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE0009355771.USD","PJP","01177","BK4588","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4533","LU0058720904.USD","LU0289739699.SGD","LU2242652126.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","BK1515","BK4599","AMGN","HK0000165453.HKD","LU0122379950.USD","IE00BZ08YR35.GBP","LU0868494617.USD","IE00BZ08YS42.EUR","BK4581","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4585","BK1589","LU0889565916.HKD","IE00B2B36J28.USD","BBH","LU1983299246.USD","IE00BFTCPJ56.SGD","PBE","LU1571399168.USD","IBB","LU0109394709.USD","LU1061106388.HKD","BK1521","BK4139","SG9999001440.SGD","BK4566","BIB","LU2089984988.USD","LU2112291526.USD","IE0002141913.USD","IE00BZ08YT58.USD","BK1191","IBBQ","LU0320765992.SGD","LU2242646821.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662215752","title":"Biogen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662215752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662215752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:59","pubTimestamp":1787691540,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.21% to $220.77 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Biogen Inc. closed 0.62% short of its 52-week high of $222.15, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and AbbVie Inc.  rose 0.48% to $265.79.Trading volume  remained 712,698 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4533","BMED","LU0109394709.USD","BK4585","BIIB","LU0320765992.SGD","IE00B894F039.SGD","LU0234570918.USD","PBE","IE00B19Z9Z06.USD","LU0889565916.HKD","BK4139","IE00B19Z9P08.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370257","title":"Political and General News Events from August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662370257?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:25","pubTimestamp":1787664343,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 25Aug 25 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4N44M0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4534","IE0009355771.USD","PBE","TBXU","LU2112291526.USD","BIB","LU2089984988.USD","LU1057294990.SGD","BK4139","LU2242646821.SGD","LU0320765992.SGD","AMGN","BK4566","BK4588","LU0889565916.HKD","LU2468319806.SGD","LU0868494617.USD","LU2242652126.USD","BK4585","IE0002141913.USD","LU0058720904.USD","BK4581","IE00B2B36J28.USD","BK4533","LU1023059063.AUD","SG9999001440.SGD","LU0289739699.SGD","BBH","BK4599","IE00BJT1NW94.SGD","LU0109394709.USD","PJP","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662423737","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662423737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662423737?lang=en_us&edition=fundamental","pubTime":"2026-08-25 21:15","pubTimestamp":1787663703,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF  slightly advancing and the iShares Biotechnology ETF  up 0.2%.Immatics  shares were up more than 13% after the company said it has agreed to sell about 12.9 million ordinary shares at $8.69 each, and in lieu of ordinary shares to certain investors, pre-funded warrants to buy up to approximately 4.3 million ordinary shares at $8.689 per pre-funded warrant.Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to statements from Veeva. Shares of Veeva Systems were down 0.1% premarket.Bausch + Lomb  stock was up more than 1% after the company said it plans to advance two of its pharmaceutical pipeline assets to new trials based on latest clinical results.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBH","BIIB","BLCO","VEEV","IBB","LU2237438978.USD","IE00B894F039.SGD","BK4198","LU0114720955.EUR","BK4613","BK4139","LU2468319806.SGD","IBBQ","LU1974910355.USD","XBI","LU0029874061.USD","LU2362540622.SGD","BK4534","XLV","LU0889565916.HKD","PBE","REGN","BK4528","LU0053666078.USD","LU0823434740.USD","LU0882574055.USD","BK4504","LABU","LGHT","IE00B19Z9P08.USD","LU0058720904.USD","LU0109394709.USD","BMED","BK4532","LU0170899867.USD","BK4588","LU2362541273.HKD","BK4533","BK4581","IMTX","LU0289739699.SGD","TBXU","LU1917777945.USD","LU0128526141.USD","HCSG","LU2089984988.USD","LU0320765992.SGD","EKG","LU0234570918.USD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731506","title":"Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731506","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:41","pubTimestamp":1787658092,"startTime":"0","endTime":"0","summary":"Veeva Systems  has signed Biogen  and Regeneron Pharmaceuticals  as new users for its Veeva Vault CRM platform, according to Tuesday statements from Veeva.No financial details were disclosed.Biogen will use Veeva Vault CRM as its agentic commercial foundation to deliver drugs to patients, while Regeneron plans to use the platform to generate commercial evidence that will back treatment adoption, Veeva said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0882574055.USD","BK4613","LU1974910355.USD","LU0289739699.SGD","BK4139","BIIB","REGN","IBBQ","LU0823416689.USD","LU2362541273.HKD","BK4585","LU0109394709.USD","LU0053666078.USD","LGHT","BK4534","BK4588","BK4504","LU0058720904.USD","LU1989764664.SGD","LU0234570918.USD","LU2023250504.SGD","LU0114720955.EUR","EKG","LU1989764748.USD","LU2362541513.USD","LU1917777945.USD","LU2468319806.SGD","IE00B894F039.SGD","LU0823434583.USD","LU0889565916.HKD","BK4167","BK4528","BK4532","IE00B19Z9P08.USD","LU0823434740.USD","TBXU","IBB","LU0320765992.SGD","LU0170899867.USD","IE00B19Z9Z06.USD","LU0266013472.USD","VEEV","LU2362540622.SGD","LU2089984988.USD","LU2237438978.USD","LU2106854487.HKD","PBE","BBH","BMED","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1551013425.SGD","EXI","IE00B19Z9P08.USD","LU1988902786.USD","MDCO","NATO","BK4082","BK4139","LU1366192091.USD","LU2543165471.USD","LU0354030438.USD","LU1280957306.USD","BK4581","ONC","TRUI","LU0689472784.USD","UXI","BK4526","LU0109394709.USD","LU0354030511.USD","LU0353189763.USD","BIIB","LU0889565916.HKD","LU0077335932.USD","XAR","LU0868494617.USD","LU1066051498.USD","LU2264538146.SGD","LU2756315664.SGD","LU2168564065.EUR","XLV","LU0689626769.HKD","XBI","DFEN","BK4543","ITA","PBE","BMED","BK4588","GE","LU1551013342.USD","BK4187","LU2168564222.USD","PPA","GEHC","LABU","MISL","IE00B894F039.SGD","LGHT","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662786682","title":"Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2662786682","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662786682?lang=en_us&edition=fundamental","pubTime":"2026-08-25 12:37","pubTimestamp":1787632638,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) has launched Vertex 6.0, a new version of its channel emulation platform designed for 6G and Wi-Fi 7/8 testing. Investors are assessing what this expanded wireless testing capability might imply for the stock.\nSee our latest analysis for Viavi Solutions.\nThe Vertex 6.0 launch arrives after a sharp pullback in Viavi Solutions' share price, with the stock down 20.13% over the past week and 31.31% over 90 days. However, year to date the share price return is 103.58% and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/viavi-solutions-viav-could-be-40-undervalued-on-vertex-60-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z3581.USD","IE00B19Z9P08.USD","LU1093756168.USD","VRTX","IE0009355771.USD","LU1559883803.SGD","TBXU","LU2237438978.USD","BIB","IE00B894F039.SGD","VIAG","BK4020","IE0002270589.USD","IE00BFTCPJ56.SGD","BBH","LU2462157665.USD","IE0002141913.USD","IDNA","IE00B4R5TH58.HKD","VERX","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU2236285917.USD","LU2362540622.SGD","IBBQ","LU0205194284.USD","PBE","SG9999013999.USD","LU1585245621.USD","LU0289739699.SGD","LU2065171311.SGD","VIAV","IBB","BK4023","LU0079474960.USD","LU0757428866.USD","LU1093756325.SGD","LU2468319806.SGD","LU2065170008.USD","LU2417539215.USD","LU0240877869.USD","LU2089984988.USD","BK4567","GNMX","LU1778281490.HKD","LU2065169927.USD","BK4139","LU2362541273.HKD","LU0234570918.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206197","title":"Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206197","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206197?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.03% to $443.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.26% to 53,417.16 and the S&P 500 Index  falling 0.28% to 7,652.86.This was the stock's second consecutive day of gains.Amgen Inc. hit a new 52-week high, surpassing its previous peak of $443.20, which the company reached on August 19th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 1.04% to $273.04, Pfizer Inc.  fell 0.36% to $27.97, and AbbVie Inc.  fell 0.17% to $264.52.Trading volume  remained 382,792 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","TBXU","IBBQ","PBE","LU1023059063.AUD","BK4534","LU2242646821.SGD","LU0109394709.USD","LU2242652126.USD","AMGN","IBB","LU2468319806.SGD","IE00BJT1NW94.SGD","04332","BK4533","LU2089984988.USD","BIB","BK4588","BK4585","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","SG9999001440.SGD","PJP","LU0289739699.SGD","BBH","BK4581","LU0058720904.USD","BK4139","LU1057294990.SGD","LU2112291526.USD","LU1983299246.USD","BK4566","IE0002141913.USD","LU0868494617.USD","LU1061106388.HKD","IE0009355771.USD","LU0122379950.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4599","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}